Scholarlink

<p>Snakebite, a neglected tropical disease is a major cause of mortality and morbidity in India, despite which reliable nationwide data are limited. To address this, we carried out a survey in 25 districts across 11 states, covering a 60 million population. The community-based study was led by frontline health workers who tracked cases and deaths, while field teams collected details on the bite, the type of snake, treatment received, and costs. Data were gathered continuously for a one-year period. Here we show that 7,094 snakebite cases were recorded, with a mortality rate of 0.33 per 100,000 population. Nearly half of the reported deaths occurred outside hospital settings. Bites were most common in males (64.1%), adults aged 30–39 years (20.9%), and during the monsoon season (62.1%). Most victims (86.4%) sought hospital care, 60.2% received anti-snake venom, and 17.2% experienced side effects to the anti-venom. Treatment placed a heavy financial burden on families; average out-of-pocket expenditure was INR 6,500, with higher costs in private hospitals (INR 27,400) compared to public facilities (INR 3,900). And 47.5% of the victims belonged to households below the poverty line. These findings show that faster access to hospitals, improved anti-venoms, and health insurance are urgently needed to prevent avoidable deaths.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Cross-sectional survey of the incidence, mortality and socioeconomic burden of snakebite envenoming in India

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月10日

查看全文
  • Jaideep C. Menon,
  • Omesh Kumar Bharti,
  • Aravind M S,
  • H. S. Bawaskar,
  • Amarendra Mohapatra,
  • Dileep Punde,
  • Rahul K. Gajbhiye,
  • B. N. Mohapatra,
  • Chakradhar Majhi,
  • Vikas Dhikav,
  • M. Bhaskar,
  • Sunil Kumar Raina,
  • Sadanand Raut,
  • Smita D. Mahale,
  • Hrishikesh Munshi,
  • Paramjeet Singh,
  • Arun Joshi,
  • Sadhana Awasthi,
  • Subhash Bahuguna,
  • R. K. Soni,
  • Arunabha Dasgupta,
  • Subrata Baidya,
  • R. K. Sood,
  • Rajesh Guleri,
  • Dinesh Kumar,
  • Suresh Yadav,
  • Ramesh Kumar Sangwan,
  • Joseph K. Joseph,
  • Pillay V.V,
  • P. D. Tanwar,
  • Sreekrishnan T.P,
  • Sabarish B. Nair,
  • Siddhartha Debbarma,
  • S. K. Sharma,
  • Dipankar Biswas,
  • Kaustubh Bora,
  • J. Mahanta,
  • Swati Patki,
  • Vanlalduhsaki Ralte,
  • Mimi Ngente,
  • H. T. Lalremsanga,
  • Tana Takum,
  • Nabam Peter,
  • Taso Beyong,
  • J. K. Chakma,
  • Geetha R. Menon,
  • R. S. Dhaliwal,
  • Swati Allen,
  • Denny John,
  • Priyanka Kadam,
  • Srikanta Kanungo,
  • Sanghamitra Pati

摘要

Snakebite, a neglected tropical disease is a major cause of mortality and morbidity in India, despite which reliable nationwide data are limited. To address this, we carried out a survey in 25 districts across 11 states, covering a 60 million population. The community-based study was led by frontline health workers who tracked cases and deaths, while field teams collected details on the bite, the type of snake, treatment received, and costs. Data were gathered continuously for a one-year period. Here we show that 7,094 snakebite cases were recorded, with a mortality rate of 0.33 per 100,000 population. Nearly half of the reported deaths occurred outside hospital settings. Bites were most common in males (64.1%), adults aged 30–39 years (20.9%), and during the monsoon season (62.1%). Most victims (86.4%) sought hospital care, 60.2% received anti-snake venom, and 17.2% experienced side effects to the anti-venom. Treatment placed a heavy financial burden on families; average out-of-pocket expenditure was INR 6,500, with higher costs in private hospitals (INR 27,400) compared to public facilities (INR 3,900). And 47.5% of the victims belonged to households below the poverty line. These findings show that faster access to hospitals, improved anti-venoms, and health insurance are urgently needed to prevent avoidable deaths.